|

Vinorelbine Tartrate Oral Clinical Trials

1 actively recruiting trial

▼ -1 trial since June 2026

Also known as: Navelbine

Pipeline

Phase 3: 1

Top Sponsors

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Indications

  • HRD-positive/HER2-negative Advanced Breast Cancer1
  • Fludzoparib" and Anti-angiogenic1
  • Breast Cancer1
  • Cancer1

Other1 trial

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.